Page last updated: 2024-09-03

imatinib mesylate and Chronic Hepatitis C

imatinib mesylate has been researched along with Chronic Hepatitis C in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Khatun, M; Long, J; Nazzal, M; Patra, T; Phillips, N; Ray, R; Ray, RB; Steele, R; Sur, S	1
Camilleri, M	1

Reviews

1 review(s) available for imatinib mesylate and Chronic Hepatitis C

Article	Year
GI clinical research 2002-2003: the year in review. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2003, Volume: 1, Issue:6 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Benzamides; Biomedical Research; Colorectal Neoplasms; Gastrointestinal Diseases; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Imatinib Mesylate; Irritable Bowel Syndrome; Peptic Ulcer Hemorrhage; Piperazines; Pyrimidines; Risk Factors; Stomach Neoplasms	2003

Article

Year

GI clinical research 2002-2003: the year in review.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2003, Volume: 1, Issue:6

Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Benzamides; Biomedical Research; Colorectal Neoplasms; Gastrointestinal Diseases; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Imatinib Mesylate; Irritable Bowel Syndrome; Peptic Ulcer Hemorrhage; Piperazines; Pyrimidines; Risk Factors; Stomach Neoplasms

2003

Other Studies

1 other study(ies) available for imatinib mesylate and Chronic Hepatitis C

Article	Year
Establishment of a Patient-Derived Xenograft Tumor From Hepatitis C-Associated Liver Cancer and Evaluation of Imatinib Treatment Efficacy. Hepatology (Baltimore, Md.), 2020, Volume: 72, Issue:2 Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Disease Models, Animal; Hepatitis C, Chronic; Heterografts; Humans; Imatinib Mesylate; Liver Neoplasms; Mice; Neoplasm Transplantation; Treatment Outcome; Xenograft Model Antitumor Assays	2020

Article

Year

Establishment of a Patient-Derived Xenograft Tumor From Hepatitis C-Associated Liver Cancer and Evaluation of Imatinib Treatment Efficacy.

Hepatology (Baltimore, Md.), 2020, Volume: 72, Issue:2

Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Disease Models, Animal; Hepatitis C, Chronic; Heterografts; Humans; Imatinib Mesylate; Liver Neoplasms; Mice; Neoplasm Transplantation; Treatment Outcome; Xenograft Model Antitumor Assays

2020